Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia–reperfusion injury
2018 · Biomedicine & Pharmacotherapy · 33 citations
https://doi.org/10.1016/j.biopha.2018.12.031
D
Daopeng Dai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
374
Citations
9
h-index
9
i10-index
Daopeng Dai is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Cardiac Fibrosis and Remodeling & Atherosclerosis and Cardiovascular Diseases & Chronic Kidney Disease and Diabetes. The author has an h-index of 9, co-authored 17 publications.
Papers by this author
worksUsing circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease
2021 · BMC Nephrology · 32 citations
https://doi.org/10.1186/s12882-021-02268-3
Serum sLYVE-1 is not associated with coronary disease but with renal dysfunction: a retrospective study
2019 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-019-47367-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat